If you have latent tuberculosis, you may need to take only one or two types of TB drug. Active tuberculosis, particularly if it's a drug-resistant strain, will require several drugs at once. The most common medications used to treat tuberculosis include:
Isoniazid
Rifampin (Rifadin, Rimactane)
Ethambutol (Myambutol)
Pyrazinamide
This report aims to provide a comprehensive presentation of the global market for Tuberculosis (TB) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis (TB) Treatment. This report contains market size and forecasts of Tuberculosis (TB) Treatment in global, including the following market information:
Global Tuberculosis (TB) Treatment Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Tuberculosis (TB) Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Isoniazid Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Tuberculosis (TB) Treatment include Johnson & Johnson, Otsuka Pharmaceutical Co., Ltd, Macleods Pharmaceutical Ltd, Dong-A ST Co., Ltd, Lupin Ltd, Janssen Products, LP, Mylan and Sanofi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Tuberculosis (TB) Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tuberculosis (TB) Treatment Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Tuberculosis (TB) Treatment Market Segment Percentages, by Type, 2022 (%)
Isoniazid
Rifampin (Rifadin, Rimactane)
Ethambutol (Myambutol)
Pyrazinamide
Global Tuberculosis (TB) Treatment Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Tuberculosis (TB) Treatment Market Segment Percentages, by Application, 2022 (%)
Active TB
Latent TB
Global Tuberculosis (TB) Treatment Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Tuberculosis (TB) Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tuberculosis (TB) Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Tuberculosis (TB) Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Otsuka Pharmaceutical Co., Ltd
Macleods Pharmaceutical Ltd
Dong-A ST Co., Ltd
Lupin Ltd
Janssen Products, LP
Mylan
Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Tuberculosis (TB) Treatment, market overview.
Chapter 2: Global Tuberculosis (TB) Treatment market size in revenue.
Chapter 3: Detailed analysis of Tuberculosis (TB) Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tuberculosis (TB) Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Tuberculosis (TB) Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tuberculosis (TB) Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tuberculosis (TB) Treatment Overall Market Size
2.1 Global Tuberculosis (TB) Treatment Market Size: 2022 VS 2032
2.2 Global Tuberculosis (TB) Treatment Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Tuberculosis (TB) Treatment Players in Global Market
3.2 Top Global Tuberculosis (TB) Treatment Companies Ranked by Revenue
3.3 Global Tuberculosis (TB) Treatment Revenue by Companies
3.4 Top 3 and Top 5 Tuberculosis (TB) Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Tuberculosis (TB) Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tuberculosis (TB) Treatment Players in Global Market
3.6.1 List of Global Tier 1 Tuberculosis (TB) Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Tuberculosis (TB) Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Tuberculosis (TB) Treatment Market Size Markets, 2022 & 2032
4.1.2 Isoniazid
4.1.3 Rifampin (Rifadin, Rimactane)
4.1.4 Ethambutol (Myambutol)
4.1.5 Pyrazinamide
4.2 By Type - Global Tuberculosis (TB) Treatment Revenue & Forecasts
4.2.1 By Type - Global Tuberculosis (TB) Treatment Revenue, 2018-2023
4.2.2 By Type - Global Tuberculosis (TB) Treatment Revenue, 2024-2032
4.2.3 By Type - Global Tuberculosis (TB) Treatment Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tuberculosis (TB) Treatment Market Size, 2022 & 2032
5.1.2 Active TB
5.1.3 Latent TB
5.2 By Application - Global Tuberculosis (TB) Treatment Revenue & Forecasts
5.2.1 By Application - Global Tuberculosis (TB) Treatment Revenue, 2018-2023
5.2.2 By Application - Global Tuberculosis (TB) Treatment Revenue, 2024-2032
5.2.3 By Application - Global Tuberculosis (TB) Treatment Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Tuberculosis (TB) Treatment Market Size, 2022 & 2032
6.2 By Region - Global Tuberculosis (TB) Treatment Revenue & Forecasts
6.2.1 By Region - Global Tuberculosis (TB) Treatment Revenue, 2018-2023
6.2.2 By Region - Global Tuberculosis (TB) Treatment Revenue, 2024-2032
6.2.3 By Region - Global Tuberculosis (TB) Treatment Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Tuberculosis (TB) Treatment Revenue, 2018-2032
6.3.2 US Tuberculosis (TB) Treatment Market Size, 2018-2032
6.3.3 Canada Tuberculosis (TB) Treatment Market Size, 2018-2032
6.3.4 Mexico Tuberculosis (TB) Treatment Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Tuberculosis (TB) Treatment Revenue, 2018-2032
6.4.2 Germany Tuberculosis (TB) Treatment Market Size, 2018-2032
6.4.3 France Tuberculosis (TB) Treatment Market Size, 2018-2032
6.4.4 U.K. Tuberculosis (TB) Treatment Market Size, 2018-2032
6.4.5 Italy Tuberculosis (TB) Treatment Market Size, 2018-2032
6.4.6 Russia Tuberculosis (TB) Treatment Market Size, 2018-2032
6.4.7 Nordic Countries Tuberculosis (TB) Treatment Market Size, 2018-2032
6.4.8 Benelux Tuberculosis (TB) Treatment Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Tuberculosis (TB) Treatment Revenue, 2018-2032
6.5.2 China Tuberculosis (TB) Treatment Market Size, 2018-2032
6.5.3 Japan Tuberculosis (TB) Treatment Market Size, 2018-2032
6.5.4 South Korea Tuberculosis (TB) Treatment Market Size, 2018-2032
6.5.5 Southeast Asia Tuberculosis (TB) Treatment Market Size, 2018-2032
6.5.6 India Tuberculosis (TB) Treatment Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Tuberculosis (TB) Treatment Revenue, 2018-2032
6.6.2 Brazil Tuberculosis (TB) Treatment Market Size, 2018-2032
6.6.3 Argentina Tuberculosis (TB) Treatment Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Tuberculosis (TB) Treatment Revenue, 2018-2032
6.7.2 Turkey Tuberculosis (TB) Treatment Market Size, 2018-2032
6.7.3 Israel Tuberculosis (TB) Treatment Market Size, 2018-2032
6.7.4 Saudi Arabia Tuberculosis (TB) Treatment Market Size, 2018-2032
6.7.5 UAE Tuberculosis (TB) Treatment Market Size, 2018-2032
7 Tuberculosis (TB) Treatment Companies Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Tuberculosis (TB) Treatment Major Product Offerings
7.1.4 Johnson & Johnson Tuberculosis (TB) Treatment Revenue in Global Market (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Otsuka Pharmaceutical Co., Ltd
7.2.1 Otsuka Pharmaceutical Co., Ltd Company Summary
7.2.2 Otsuka Pharmaceutical Co., Ltd Business Overview
7.2.3 Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Major Product Offerings
7.2.4 Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Revenue in Global Market (2018-2023)
7.2.5 Otsuka Pharmaceutical Co., Ltd Key News & Latest Developments
7.3 Macleods Pharmaceutical Ltd
7.3.1 Macleods Pharmaceutical Ltd Company Summary
7.3.2 Macleods Pharmaceutical Ltd Business Overview
7.3.3 Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Major Product Offerings
7.3.4 Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Revenue in Global Market (2018-2023)
7.3.5 Macleods Pharmaceutical Ltd Key News & Latest Developments
7.4 Dong-A ST Co., Ltd
7.4.1 Dong-A ST Co., Ltd Company Summary
7.4.2 Dong-A ST Co., Ltd Business Overview
7.4.3 Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Major Product Offerings
7.4.4 Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Revenue in Global Market (2018-2023)
7.4.5 Dong-A ST Co., Ltd Key News & Latest Developments
7.5 Lupin Ltd
7.5.1 Lupin Ltd Company Summary
7.5.2 Lupin Ltd Business Overview
7.5.3 Lupin Ltd Tuberculosis (TB) Treatment Major Product Offerings
7.5.4 Lupin Ltd Tuberculosis (TB) Treatment Revenue in Global Market (2018-2023)
7.5.5 Lupin Ltd Key News & Latest Developments
7.6 Janssen Products, LP
7.6.1 Janssen Products, LP Company Summary
7.6.2 Janssen Products, LP Business Overview
7.6.3 Janssen Products, LP Tuberculosis (TB) Treatment Major Product Offerings
7.6.4 Janssen Products, LP Tuberculosis (TB) Treatment Revenue in Global Market (2018-2023)
7.6.5 Janssen Products, LP Key News & Latest Developments
7.7 Mylan
7.7.1 Mylan Company Summary
7.7.2 Mylan Business Overview
7.7.3 Mylan Tuberculosis (TB) Treatment Major Product Offerings
7.7.4 Mylan Tuberculosis (TB) Treatment Revenue in Global Market (2018-2023)
7.7.5 Mylan Key News & Latest Developments
7.8 Sanofi
7.8.1 Sanofi Company Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Tuberculosis (TB) Treatment Major Product Offerings
7.8.4 Sanofi Tuberculosis (TB) Treatment Revenue in Global Market (2018-2023)
7.8.5 Sanofi Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Tuberculosis (TB) Treatment Market Opportunities & Trends in Global Market
Table 2. Tuberculosis (TB) Treatment Market Drivers in Global Market
Table 3. Tuberculosis (TB) Treatment Market Restraints in Global Market
Table 4. Key Players of Tuberculosis (TB) Treatment in Global Market
Table 5. Top Tuberculosis (TB) Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Tuberculosis (TB) Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Tuberculosis (TB) Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Tuberculosis (TB) Treatment Product Type
Table 9. List of Global Tier 1 Tuberculosis (TB) Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tuberculosis (TB) Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Tuberculosis (TB) Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Tuberculosis (TB) Treatment Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Tuberculosis (TB) Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Tuberculosis (TB) Treatment Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Tuberculosis (TB) Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Tuberculosis (TB) Treatment Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2024-2032
Table 30. Johnson & Johnson Company Summary
Table 31. Johnson & Johnson Tuberculosis (TB) Treatment Product Offerings
Table 32. Johnson & Johnson Tuberculosis (TB) Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Johnson & Johnson Key News & Latest Developments
Table 34. Otsuka Pharmaceutical Co., Ltd Company Summary
Table 35. Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Product Offerings
Table 36. Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Otsuka Pharmaceutical Co., Ltd Key News & Latest Developments
Table 38. Macleods Pharmaceutical Ltd Company Summary
Table 39. Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Product Offerings
Table 40. Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Macleods Pharmaceutical Ltd Key News & Latest Developments
Table 42. Dong-A ST Co., Ltd Company Summary
Table 43. Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Product Offerings
Table 44. Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Dong-A ST Co., Ltd Key News & Latest Developments
Table 46. Lupin Ltd Company Summary
Table 47. Lupin Ltd Tuberculosis (TB) Treatment Product Offerings
Table 48. Lupin Ltd Tuberculosis (TB) Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Lupin Ltd Key News & Latest Developments
Table 50. Janssen Products, LP Company Summary
Table 51. Janssen Products, LP Tuberculosis (TB) Treatment Product Offerings
Table 52. Janssen Products, LP Tuberculosis (TB) Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Janssen Products, LP Key News & Latest Developments
Table 54. Mylan Company Summary
Table 55. Mylan Tuberculosis (TB) Treatment Product Offerings
Table 56. Mylan Tuberculosis (TB) Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Mylan Key News & Latest Developments
Table 58. Sanofi Company Summary
Table 59. Sanofi Tuberculosis (TB) Treatment Product Offerings
Table 60. Sanofi Tuberculosis (TB) Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. Sanofi Key News & Latest Developments
List of Figures
Figure 1. Tuberculosis (TB) Treatment Segment by Type in 2022
Figure 2. Tuberculosis (TB) Treatment Segment by Application in 2022
Figure 3. Global Tuberculosis (TB) Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Tuberculosis (TB) Treatment Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Tuberculosis (TB) Treatment Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Tuberculosis (TB) Treatment Revenue in 2022
Figure 8. By Type - Global Tuberculosis (TB) Treatment Revenue Market Share, 2018-2032
Figure 9. By Application - Global Tuberculosis (TB) Treatment Revenue Market Share, 2018-2032
Figure 10. By Type - Global Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Tuberculosis (TB) Treatment Revenue Market Share, 2018-2032
Figure 12. By Application - Global Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Tuberculosis (TB) Treatment Revenue Market Share, 2018-2032
Figure 14. By Region - Global Tuberculosis (TB) Treatment Revenue Market Share, 2018-2032
Figure 15. By Country - North America Tuberculosis (TB) Treatment Revenue Market Share, 2018-2032
Figure 16. US Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Tuberculosis (TB) Treatment Revenue Market Share, 2018-2032
Figure 20. Germany Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2018-2032
Figure 21. France Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Tuberculosis (TB) Treatment Revenue Market Share, 2018-2032
Figure 28. China Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2018-2032
Figure 32. India Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Tuberculosis (TB) Treatment Revenue Market Share, 2018-2032
Figure 34. Brazil Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Tuberculosis (TB) Treatment Revenue Market Share, 2018-2032
Figure 37. Turkey Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Tuberculosis (TB) Treatment Revenue, (US$, Mn), 2018-2032
Figure 41. Johnson & Johnson Tuberculosis (TB) Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Lupin Ltd Tuberculosis (TB) Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Janssen Products, LP Tuberculosis (TB) Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Mylan Tuberculosis (TB) Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Sanofi Tuberculosis (TB) Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
